ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 25 filers reported holding ENLIVEX THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,651 | -51.6% | 44,083 | -19.4% | 0.00% | – |
| Q2 2023 | $143,900 | -41.4% | 54,715 | -18.9% | 0.00% | – |
| Q1 2023 | $245,569 | -63.0% | 67,464 | -60.3% | 0.00% | – |
| Q4 2022 | $663,515 | -55.6% | 170,132 | -51.6% | 0.00% | – |
| Q3 2022 | $1,494,000 | +1767.5% | 351,554 | +1886.2% | 0.00% | – |
| Q2 2022 | $80,000 | -42.0% | 17,700 | -19.5% | 0.00% | – |
| Q4 2021 | $138,000 | -53.8% | 22,000 | -27.4% | 0.00% | – |
| Q3 2021 | $299,000 | -28.6% | 30,300 | -35.5% | 0.00% | – |
| Q2 2021 | $419,000 | -26.0% | 47,000 | -7.8% | 0.00% | – |
| Q1 2021 | $566,000 | -35.9% | 51,000 | -51.3% | 0.00% | – |
| Q4 2020 | $883,000 | – | 104,823 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $68,000 | 0.10% |
| Susquehanna International Group Ltd. | 22,002 | $98,000 | 0.02% |
| ARK Investment Management | 331,001 | $1,658,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 50,000 | $223,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $59,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,215 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,373 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,884 | $13,000 | 0.00% |